Clinical Trial: A Real-world, Multi-center, Prospective, Observational Study for PNH in China
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Paroxysmal Nocturnal Hemoglobinuria
Study Type: OBSERVATIONAL
Official Title: A Real-world, Multi-center, Prospective, Observational Study for Paroxysmal Nocturnal Haemoglobinuria (PNH) in China
Brief Summary:
As a rare disease listed in the First Catalogue of Rare Diseases in China (National Health Commission of the People's Republic of China, 2019), PNH is poorly studied in China subse-quently leading to the inadequate elucidation of disease characteristics and clinical outcomes.Eculizumab was recently approved by NMPA.The availability of Eculizumab in China pro-vides people living with PNH with a new treatment option that can reduce disease symptoms and prevent the dysregulated complement system from causing…
Read more